Tech Company Financing Transactions
ZBiotics Funding Round
On 8/27/2024, ZBiotics raised $12 million in Series A financing from Spring Tide Capital, Goat Rodeo Capital and Seamless.
Transaction Overview
Company Name
Announced On
8/27/2024
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand distribution and bring new GMO probiotics to market.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
181 2nd St.
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Website
Email Address
Overview
Our story begins over a decade ago, when now-CEO Zack Abbott was working at an HIV research lab. There, he learned about how new, enzyme-based drugs could improve human health in profound new ways. However, he also learned that enzymes were so expensive to make that their scope was limited outside of serious drug development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Zack Abbott
Chief Operating Officer
Stephen Lamb
VP - Marketing
Kat Townsend
VP - R & D
John Oliver
Browse more venture capital transactions:
Prev: 8/27/2024: Butlr venture capital transaction
Next: 8/27/2024: Echelon venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs